The Role of Genetic Testing in Diagnosing ADTKD-HNF1B in a Pregnant Woman
DOI:
https://doi.org/10.71749/pkj.93Keywords:
Genetic Diseases, Inborn, Genetic Testing, Hepatocyte Nuclear Factor 1‑beta, Polycystic Kidney, Autosomal Dominant, PregnancyAbstract
Autosomal dominant tubulointerstitial kidney disease (ADTKD) accounts for approximately 2%‑5% of monogenic causes of chronic kidney disease (CKD) and remains frequently underrecognized due to its heterogeneous clinical presentation. We report the case of a 37‑year‑old pregnant woman diagnosed with CKD, initially attributed to chronic pyelonephritis. She presented with bilateral renal cysts, electrolyte abnormalities, uterine malformation, and a family history of CKD. Genetic testing was pursued based on the phenotypic features, identifying a novel heterozygous HNF1B variant, c.785_786dup p.(Ala263Argfs*3), classified as likely pathogenic. Subsequent familial screening revealed that the patient’s mother, who was on hemodialysis for CKD of unknown etiology, carried the same mutation, leading to the reclassification of her CKD etiology as ADTKD related to HNF1B. This case highlights the clinical variability and diagnostic challenges of HNF1B‑related ADTKD, emphasizing the crucial role of genetic testing in identifying the etiology and improving disease understanding among nephrologists.Downloads
References
Orphanet: HNF1B related autosomal dominant tubulointerstitial kidney disease. [Accessed: 04 April 2025] Available at: https://www.orpha.net/consor/cgi‑bin/OC_Exp.php?lng=EN&Expert=93111
Devuyst O, Olinger E, Weber S, Eckardt KU, Kmoch S, Rampoldi L, et al. Autosomal dominant tubulointerstitial kidney disease. Nat Rev Dis Primers. 2019;5:60. doi:10.1038/s41572-019-0109-9
Eckardt KU, Alper SL, Antignac C, Bleyer AJ, Chauveau D, Dahan K, et al. Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management – A KDIGO consensus report. Kidney Int. 2015;88:676‑83. doi:10.1038/ki.2015.28
Mabillard H, Sayer JA, Olinger E. Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease. Nephrol Dial Transplant. 2023;38:271‑82. doi:10.1093/ndt/gfab268
Clissold RL, Hamilton AJ, Hattersley AT, Ellard S, Bingham C. HNF1B-associated renal and extra-renal disease – an expanding clinical spectrum. Nat Rev Nephrol. 2015;11:102‑12. doi:10.1038/nrneph.2014.232
Verhave JC, Bech AP, Wetzels JF, Nijenhuis T. Hepatocyte nuclear factor 1β‑associated kidney disease: more than renal cysts and diabetes. J Am Soc Nephrol. 2016;27:345‑53. doi:10.1681/ASN.2015050544
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier‑Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405‑24. doi:10.1038/gim.2015.30
van der Made CI, Hoorn EJ, de la Faille R, Karaaslan H, Knoers NV, Hoenderop JG, et al. Hypomagnesemia as first clinical manifestation of ADTKD‑HNF1B: a case series and literature review. Am J Nephrol. 2015;42:85‑90. doi:10.1159/000439286
Dubois‑Laforgue D, Cornu E, Saint‑Martin C, Coste J, Bellanné‑Chantelot C, Timsit J, et al. Diabetes, associated clinical spectrum, long‑term prognosis, and genotype/phenotype correlations in 201 adult patients with hepatocyte nuclear factor 1B (HNF1B) molecular defects. Diabetes Care. 2017;40:1436‑43. doi:10.2337/dc16‑2462
Faguer S, Decramer S, Chassaing N, Hong IK, Kim HG, Lee KM, et al. Diagnosis, management, and prognosis of HNF1B nephropathy in adulthood. Kidney Int. 2011;80:768‑76. doi:10.1038/ki.2011.225
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Vítor Fernandes, Pedro Gonçalves, Alice Porto Vasconcelos, Bernardo Faria, Isabel Tavares
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
